. 2003 May;41(5):1875–1880. doi: 10.1128/JCM.41.5.1875-1880.2003

TABLE 2.

Overall interpretive agreement between results of fluconazole and voriconazole agar-based susceptibility tests and of standard 48-h BMD reference tests for 235 C. glabrata isolates

Antifungal agent	Method and medium^a	% of isolates by category^b			% of discrepant results^c			% Categorical agreement^d
Antifungal agent	Method and medium^a	S	S-DD	R	Minor	Major	Very major	% Categorical agreement^d
Fluconazole	BMD	57	36	7
	ET-RPG	32	54	14	46.0	1.7	0	52.3
	ET-MBE	44	44	12	36.6	1.7	0	61.7
	Disk	90	2	8	34.9	0	0.4	64.7
Voriconazole	BMD	93		7
	ET-RPG	92		8		2.6	2.6	94.8
	ET-MBE	93		7		1.7	2.1	96.2
	Disk	94		6		0.9	1.7	97.4

See footnote a of Table 1 for definitions of BMD, ET-RPG, ET-MBE; disk, disk diffusion test with fluconazole (25-μg disk) and voriconazole (1-μg disk).

Percentage of isolates classified in the different susceptibility categories. See Materials and Methods for definitions.

Percentage of test results with minor, major, or very major discrepancies compared to the results of the reference BMD method at 48 h. See Materials and Methods for definitions.

Agreement rates reflect the percentage of isolates classified in the same category by both the agar-based (Etest and disk) and the reference BMD methods.